Xiaowen Tang

Qingdao University — China

Medicine · Health Sciences

37h-index5.2kcitations460works3.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(145), Hematopoietic Stem Cell Transplantation(123), CAR-T cell therapy research(84), Acute Lymphoblastic Leukemia research(81), Chronic Myeloid Leukemia Treatments(61)

Publications459 total

Spatial molecular analyses reveal key features associated with response to KN026 in advanced HER2-positive breast cancer
British Journal of Cancer·2025· 1 citedOpen Access
Ruxolitinib as second-line therapy for bronchiolitis obliterans syndrome after hematopoietic cell transplantation: a retrospective multicenter study
Annals of Hematology·2025Open Access
Carbon Finance and Dynamic Capital Structure Adjustment
Preprints.org·2025Open Access
The interleukin‐6 connection: Understanding cytomegalovirus reactivation following <scp>CAR</scp> ‐T‐cell therapy
British Journal of Haematology·2025
IL-6 knockdown anti-CD19 CAR-T cells (ssCART-19) for patients with relapsed or refractory acute lymphoblastic leukemia: phase 1 trial
Blood Cancer Journal·2025Open Access
2684O ARTEMIS-002: A phase II study of HS-20093 in patients with relapsed or refractory sarcomas
Annals of Oncology·2025
Effective Management of Carbapenem-Resistant Enterobacterales Bloodstream Infection with Organ Dissemination in Prolonged Severe Agranulocytosis Patients with Hematological Malignancy Through Combination Therapies Including Eravacycline
Infectious Diseases and Therapy·2025Open Access
Effect of sorafenib on prognosis in patients with low-allelic-ratio FLT3-ITD acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation
Leukemia Research·2025
Tandem <scp>CD19</scp>/<scp>CD22 CAR</scp> T‐Cell Therapy as First‐Line Treatment for Adult Patients With High‐Risk Philadelphia Chromosome Negative B‐Cell Acute Lymphoblastic Leukemia
American Journal of Hematology·2025· 2 citedOpen Access
First-in-human study of JSKN016, a bispecific anti-TROP2/HER3 antibody drug conjugate (ADC): Antitumor activity in patients (pts) with metastatic triple-negative breast cancer (mTNBC) and safety results.
Journal of Clinical Oncology·2025· 4 cited
Supplementary Table S3 from Cladribine Added to Idarubicin and Cytarabine as an Induction Regimen for Patients with &lt;i&gt;De Novo&lt;/i&gt; Acute Myeloid Leukemia: A Multicenter, Randomized Phase III Trial
2025Open Access
Supplementary Table S2 from Cladribine Added to Idarubicin and Cytarabine as an Induction Regimen for Patients with &lt;i&gt;De Novo&lt;/i&gt; Acute Myeloid Leukemia: A Multicenter, Randomized Phase III Trial
2025Open Access
Supplementary Table S5 from Cladribine Added to Idarubicin and Cytarabine as an Induction Regimen for Patients with &lt;i&gt;De Novo&lt;/i&gt; Acute Myeloid Leukemia: A Multicenter, Randomized Phase III Trial
2025Open Access
Supplementary Table S1 from Cladribine Added to Idarubicin and Cytarabine as an Induction Regimen for Patients with &lt;i&gt;De Novo&lt;/i&gt; Acute Myeloid Leukemia: A Multicenter, Randomized Phase III Trial
2025Open Access
Data from Cladribine Added to Idarubicin and Cytarabine as an Induction Regimen for Patients with &lt;i&gt;De Novo&lt;/i&gt; Acute Myeloid Leukemia: A Multicenter, Randomized Phase III Trial
2025Open Access
Supplementary Table S4 from Cladribine Added to Idarubicin and Cytarabine as an Induction Regimen for Patients with &lt;i&gt;De Novo&lt;/i&gt; Acute Myeloid Leukemia: A Multicenter, Randomized Phase III Trial
2025Open Access
CD19 CAR-T in relapsed t(8;21) AML: a single-center prospective phase II clinical trial
Journal of Hematology & Oncology·2025· 13 citedOpen Access
Real-world Efficacy and Safety of Flumatinib as the First-line Treatment in Patients With de novo Philadelphia-positive Acute Lymphoblastic Leukemia
Clinical Lymphoma Myeloma & Leukemia·2025· 1 cited
Clinical Outcomes of CD7 CAR‐T Cell Therapy in Relapsed or Refractory T‐Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Patients
Hematological Oncology·2025· 2 cited
Identification of rare recurrent <i>FNBP1::JAK2</i> fusion in myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions
Leukemia & lymphoma/Leukemia and lymphoma·2025
page 1 of 23Next →

Frequent Co-authors

Depei Wu(13), Depei Wu(11), Min‐Xin Guan(11), Haiping Dai(10), Yi Zhu(10), Jianxin Lü(9), Li Yang(9), Jindan Wang(8), Xinliang Mao(8), Jia Chen(8), Xiaming Zhu(7), Aifen Yang(7), Liqing Kang(7), Suning Chen(7), Yue Han(7), Nan Xu(6), Lei Yu(6), Qiaoling Yang(6), Zhengtao Wang(6), Li Yang(6)